Perceptive Advisors »

Newamsterdam Pharma Co Nv shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $17M 500k 33.89
2024-03-31 $4.1M 175k 23.65

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Spyre Therapeutics Com New (SYRE)
Celcuity (CELC)
Ascendis Pharma A/s Ord Shs (ASND)
Rhythm Pharmaceuticals (RYTM)
Roivant Sciences SHS (ROIV)
Relay Therapeutics (RLAY)
Travere Therapeutics (TVTX)
Kardigan Ord
Nuvalent Inc-a (NUVL)
Edgewise Therapeutics (EWTX)
Apogee Therapeutics (APGE)
Amylyx Pharmaceuticals (AMLX)
Meiragtx Holdings (MGTX)
Oruka Therapeutics (ORKA)

View all positions for Perceptive Advisors

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
FMR
RA Capital Management
Fcpm Iii Services B.v.
Deerfield Management Company
Viking Global Investors
Bain Capital Life Sciences Investors
Maverick Capital
Duquesne Family Office
Jupiter Topco
Henderson Group
Medicxi Ventures Management
Jennison Associates
Orbis Allan Gray

View all funds holding Newamsterdam Pharma Co Nv